Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA
prnewswire.com
MCI.VMCI.VTSXV
Loading
Alerts
Want to monitor MCI.V?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor MCI.VNews
Aflac celebrates 20 years as a World's Most Ethical Company
prnewswire.com
Mosaic's Rare Earths Bet Could Revalue the Stock: What That Means for Investors
247wallst.com
Truist announces first quarter 2026 earnings call details
prnewswire.com
AirSculpt Technologies Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
FLUENT Corp. Announces Amendment to Senior Secured Credit Agreement
globenewswire.com
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
newsfilecorp.com
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
globenewswire.com
Steer Clear Of The Braiin AI Listing
seekingalpha.com
Spectral Capital on Track to Meet or Exceed 2026 Revenue Guidance of $450 Million with Over $200 Million Generated in First Two Months of the Year
prnewswire.com
Boyd Group Services Inc. (BGSI) Q4 Earnings Top Estimates
zacks.com
Docusign: Stabilizing Business At A Great Price
seekingalpha.com
Jabil Lifts Outlook as Profit, Revenue Rise
wsj.com
TransUnion Strengthens Device Security with New Machine Learning Capabilities
globenewswire.com
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study
globenewswire.com
PepsiCo Named Official Beverage Partner of VENU's Premium Sunset Amphitheater Portfolio
businesswire.com
uCloudlink Group Inc. Sponsored ADR (UCL) Reports Q4 Loss, Misses Revenue Estimates
zacks.com
2 Stocks I'm Buying for the Future of AI Work
247wallst.com
Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis
accessnewswire.com
NAPC Defense, Inc. Positioned as Primary Subcontractor on Obera Portfolio Following Asset Acquisition by Native American Pride Constructors, LLC
globenewswire.com